The Prevent Cancer Foundation has released the results of a survey conducted with 2000+ women and people assigned female at birth in the U.S, that shows that women are skipping cancer screenings during the pandemic. 90% of women say when local pandemic restrictions were lifted, they engaged in normal activities, such as visiting family and friends, dining out and shopping, but only 48%…
FUJIFILM, a provider of diagnostic imaging and medical informatics solutions, has announced that its ASPIRE Cristalle mammography system with digital breast tomosynthesis (DBT) now offers ScreenPoint Medical’s new, FDA cleared Transpara powered by Fusion AI for 2D and 3D mammography in the United States. ScreenPoint Medical’s AI solution, coupled with the ASPIRE Cristalle mammography system, displays breast screening findings at a doctor’s reading workstation or PACS…
AOA Dx has signed an Exclusive License Agreement with Professor H. Uri Saragovi, a Senior Investigator with the Lady Davis Institute at the Jewish General Hospital and Professor at McGill University, to secure a suite of IP related to utilizing gangliosides for early cancer detection through liquid biopsies. A family of gangliosides function as tumor markers, as they are low or absent…
Women’s health startup Mammogen has announced the closing of its $2M seed round. The round was oversubscribed by a diverse group of high-net-worth investors, comprising 52% women, members of the LGBTQ+ community, and veterans from the US Armed Forces, according to the company. “The vast diversity across our investor base is evidence that the world is ready for a truly differentiated women’s health narrative,”…
AOA Dx earlier today announced that they have been accepted to Y Combinator’s 2021 summer cohort and have closed a $2.5 million seed round to develop AKRIVIS GD, a liquid biopsy test that is set to revolutionize the future of ovarian cancer diagnostics. AOA Dx has been working in close collaboration with world renowned cancer researcher Professor H. Uri Saragovi, Senior Investigator…
The Black Women’s Health Imperative (BWHI) and Hologic’s Project Health Equality today announced the launch of Cerving Confidence, a collaboration featuring Grammy Award-winning singer-songwriter Ciara that encourages Black women to commit to their well-woman exams as a part of self-care and protect themselves against cervical cancer. Cerving Confidence offers life-saving information and screening access to help prevent cervical cancer in Black women, who are disproportionately…
Aspira Women’s Health, a bioanalytical-based women’s health company focused on gynecologic disease and The Feinstein Institutes for Medical Research, the science arm of Northwell Health, the largest private Healthcare Provider in New York State, today announced the start of a prospective Clinical Study for Ovarian Cancer Risk Detection. Northwell Health treats over 2 million patients annually and employs over 16,000 credentialled physicians. The…
Roche today announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel for advanced or recurrent endometrial cancer patients. MMR is a molecular mechanism that functions to correct certain errors that can spontaneously occur during DNA replication. Testing can identify patients eligible for treatment with JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD1 immunotherapy from GlaxoSmithKline (GSK) that was approved by…
